Michael Wiley

Michael Wiley is an accomplished professional in the field of drug discovery and research, currently serving as President of Wiley Drug Discovery Consulting LLC since February 2020 and as a Scientific Advisory Board Member at ECCOGENE since March 2020. Prior to these roles, Michael Wiley was a Research Fellow at Eli Lilly and Company from May 1990 to January 2020. Educationally, Michael Wiley holds a PhD in Chemistry from the University of Utah, completed an NIH Postdoctoral Fellowship at Columbia University, and earned a BS in Chemistry from Graceland University.